Trivium Point Advisory’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$365K Buy
+4,021
New +$367K 0.03% 284
2026
Q1
Sell
-2,743
Closed -$344K 271
2025
Q4
$344K Sell
2,743
-101
-4% -$12.9K 0.03% 283
2025
Q3
$381K Sell
2,844
-745
-21% -$97.8K 0.04% 267
2025
Q2
$488K Buy
3,589
+74
+2% +$9.76K 0.05% 237
2025
Q1
$466K Buy
3,515
+477
+16% +$60.7K 0.06% 237
2024
Q4
$344K Buy
3,038
+926
+44% +$107K 0.04% 271
2024
Q3
$244K Buy
+2,112
New +$232K 0.03% 301
2022
Q2
Sell
-1,670
Closed -$200K 204
2022
Q1
$200K Buy
1,670
+98
+6% +$12.1K 0.04% 217
2021
Q4
$221K Buy
+1,572
New +$201K 0.05% 220

Other funds holding ABT

Trivium Point Advisory's ABT Position: Q2 2026 in Review

Trivium Point Advisory opened a new position in Abbott (ABT) in Q2 2026: 4,021 shares worth $365K. The stake represents 0.03% of the portfolio and ranks #284 among its holdings. This is a return to the name: Trivium Point Advisory previously reported a position in ABT as recently as Q4 2025.

Trivium Point Advisory first reported a position in ABT in Q4 2021 and has held it in 9 quarters since. The position peaked at $488K in Q2 2025. 2,950 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Trivium Point Advisory held 4,021 shares of Abbott worth $365K as of Q2 2026.
  • Abbott was a new Trivium Point Advisory position in Q2 2026.
  • Abbott made up 0.03% of Trivium Point Advisory's portfolio in Q2 2026, its #284 holding.
  • Trivium Point Advisory first reported a position in Abbott in Q4 2021 and has held it in 9 quarters since.
  • Trivium Point Advisory's Abbott position peaked at $488K in Q2 2025.
  • 2,950 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Trivium Point Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.